Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02159586 · ClinicalTrials.gov registry record

Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve

A clinical trial of Gastroparesis, sponsored by Indiana University.

Active
Registry status
300
Enrollment target
1
Study location

NCT02159586 is a study of Gastroparesis that is active but no longer recruiting, run by Indiana University. The registered enrollment target is 300 participants, roughly in line with the 295-participant average among 44 other Gastroparesis trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02159586, a study of Gastroparesis, is active but no longer recruiting, sponsored by Indiana University.

ACTIVE NOT RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine if Gastric Electrical Stimulation may influence vagal outflow via vagal afferent fibers that terminate in the Central Nervous System.

Conditions Studied

Interventions

  • DEVICE gastric electrical stimulator

Study Locations (1)

Indiana

  • Indiana University Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2012-11-01
Est. Completion 2027-12

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT02159586

The ClinicalTrials.gov registry entry for NCT02159586 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 295-participant average among 44 other Gastroparesis trials with a reported enrollment target. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which gastric electrical stimulator is the first listed.

NCT02159586 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT02159586 about?

NCT02159586 is a clinical study titled "Cardiac Vagal Effects of GES in Patients With Gastroparesis and Vagal Nerve Action Potentials in Vagus Nerve". The objective of this study is to determine if Gastric Electrical Stimulation may influence vagal outflow via vagal afferent fibers that terminate in the Central Nervous System.

What is the current status of trial NCT02159586?

This trial is currently active not recruiting. The enrollment target is 300 participants. The study started on 2012-11-01. Estimated completion is 2027-12.

What conditions does trial NCT02159586 study?

This clinical trial studies the following conditions: Gastroparesis.

What interventions are being tested in trial NCT02159586?

The interventions under investigation include: gastric electrical stimulator (DEVICE).

Who is sponsoring clinical trial NCT02159586?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02159586 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.